Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Colchicine in HFpEF and Systemic Inflammation
NCT06130059Phase 2Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2024
- Primary completion
- Jul 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in heart failure with preserved ejection fraction (HFpEF), sponsored by UT Southwestern Medical Center. Started Apr 2024; status: recruiting.
02
Drugs
colchicine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT06130059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06130059.